The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they ...

These heart cells rupture and leak DNA, which sparks a damaging immune response. This breakthrough challenges long-held ...

Malcolm Fairley, who became known as 'The Fox', carried out a series of sex attacks across Bedfordshire, Buckinghamshire and ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Mesoblast Limited’s MESO share price has dipped by 5.56%, which has investors questioning if this is right time to buy.

Amgen today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial ...

WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 ...

Troponin is released from damaged cell membranes only after cardiac muscle cells ... Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart. Rev Esp ...

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...

The Hummingbird Diagnostics Product Pipeline Analysis highlights the company's miRNA-based liquid biopsy innovations for early detection of cancer, ...